
Share on:
Joint replacement is the largest segment in orthopedics, accounting for $19 billion in revenue or 35% of the global market. Its size combined with its adoption of enabling and digital technologies makes joint replacement an attractive space for portfolio expansions, partnerships and acquisitions. Our latest market dive highlights the current and projected size of the segment; the top 10 companies in knee, hip and extremities by revenue; and key trends and executive insights.

RELATED ARTICLES
Kapstone Manufacturing to Integrate In-House DLyte Dry Electropolishing
Jun 04 2026 , Julie A. Vetalice
5 Packaging Validation Mistakes That Delay FDA Clearance
Jun 01 2026 , Matthew Emerick
Small Joint Implants: A New Era with Medureonâ„¢ Bionateâ„¢
Jun 01 2026 , dsm -firmenich



